« Back to Record
Van Cutsem, E., Cunningham, D., ten Bokkel Huinink, W., Punt, C., Alexopoulos, C., Dirix, L. Y., Symann, M., Blijham, G., Cholet, P., Fillet, G., Van Groeningen, C., Vannetzel, J. M., Lévi, F., Panagos, G., Unger, C., Wils, J., Cote, C., Blanc, C., Herait, P., & Bleiberg, H. (1999). Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). European journal of cancer, 35(1), 54-59. doi:10.1016/S0959-8049(98)00353-0
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/90306



